B12 deficiency treatment
Reading File
Finding Sources
Searching PubMed
"vitamin B12 deficiency" AND treatment
Reading File
Finding Sources
Reading Article
Reading File
Reading File
Here is a comprehensive overview of B12 deficiency treatment based on authoritative textbooks and recent evidence:
Vitamin B12 Deficiency — Treatment
1. Confirm the Diagnosis First
Before starting therapy, investigate the etiology of the deficiency:
- Macrocytic (megaloblastic) anemia, or unexplained neuropsychiatric symptoms
- Check serum B12, methylmalonic acid (MMA), and total homocysteine — both are elevated in deficiency and are sensitive/specific confirmatory tests
- Test for intrinsic factor (IF) antibodies (replaces the Schilling test in modern practice)
- Establish whether the cause is reversible (dietary, drug-induced) or permanent (pernicious anemia, ileal resection, gastrectomy)
2. Route of Administration
The critical principle: Because most B12 deficiency is caused by malabsorption, parenteral (injectable) B12 is the mainstay of therapy. Oral B12 cannot be relied on when there is marked deficiency with hematologic or neurological abnormalities.
| Route | Notes |
|---|---|
| IM / deep SC (preferred) | Bypasses absorption defect; standard for pernicious anemia and malabsorption |
| Oral (1000 mcg/day) | Can work in pernicious anemia — ~1% absorbs passively without IF; requires high doses; suitable for patients who refuse injections |
| Intranasal | 500 mcg in one nostril once weekly — for maintenance after remission is achieved |
| Sublingual | 1000–2000 mcg/day |
Hydroxocobalamin vs. Cyanocobalamin: Hydroxocobalamin is preferred for parenteral use — it is more highly protein-bound, stays longer in circulation, and requires less frequent injections. Cyanocobalamin is also effective but clears faster. — Katzung's Basic and Clinical Pharmacology, 16th Ed.
3. Dosing Regimens
Adults — B12 Deficiency (General)
- Induction (IM/SC): 100–1000 mcg/day or every other day × 1–2 weeks (to replenish body stores)
- Maintenance: 100–1000 mcg IM once a month for life (if cause is irreversible)
Adults — Pernicious Anemia
- Induction: 100 mcg IM/SC daily × 6–7 days → if improvement, 100 mcg every 3–4 days × 2–3 weeks
- Maintenance: 100 mcg IM/month; or 500 mcg intranasal weekly; or 1000–2000 mcg sublingual/day
Children — B12 Deficiency
- Induction (IM/SC): 100 mcg/day × 10–15 days, then 100 mcg once or twice weekly for several months
- Maintenance: ≥60 mcg/month
Children — Pernicious Anemia
- Induction (IM/SC): 30–50 mcg/day for ≥14 days (total dose 1000–5000 mcg)
- Maintenance: 100 mcg/month
— Harriet Lane Handbook, 23rd Ed.; Goodman & Gilman's Pharmacological Basis of Therapeutics
4. Neurological Involvement
If neurological abnormalities are present (subacute combined degeneration of the cord, peripheral neuropathy):
- Give more frequent maintenance injections — every 1–2 weeks × 6 months — before switching to monthly injections
- Neurological recovery may be incomplete if treatment is delayed
5. Acutely Ill / Severely Ill Patients
- Severely ill elderly patients may not tolerate delay; give immediate therapy with both folic acid and vitamin B12 plus supplemental blood transfusion if needed
- In uncomplicated mild-to-moderate anemia with no neurological signs: therapy can be delayed briefly for diagnostic workup; a trial of parenteral B12 1–10 mcg/day can confirm diagnosis
6. Prophylactic Supplementation
Indicated when deficiency is predictable:
- Strict vegetarians/vegans (no dietary B12)
- Post-gastrectomy patients
- Patients with inflammatory bowel disease or ileal resection
- Post-bariatric surgery patients (long-term supplementation required)
- Patients on long-term metformin or PPIs/H2 blockers (impair absorption)
When GI function is intact: oral vitamin + mineral supplement containing B12 is sufficient. Otherwise: monthly IM injections.
7. Important Cautions
- Do NOT use multivitamin/folate "shotgun" therapy alone — adequate folic acid can cause hematological recovery masking ongoing B12 deficiency, allowing neurological damage to progress silently
- Contraindicated in Leber's optic nerve atrophy (cyanocobalamin)
- Adverse effects: Hypokalemia (during recovery), hypersensitivity/anaphylaxis (rare, parenteral), pruritus, vascular thrombosis
- Monitor every 6–12 months in stable patients on long-term therapy; more frequently in pregnancy or comorbid illness
8. Recent Evidence Update
A 2024 network meta-analysis (PMID 38231320, Irish J Med Sci, 4275 patients, 13 studies) found that IM, oral, and sublingual routes all effectively raise B12 levels without statistically significant differences between them. The IM route ranked highest numerically for raising serum B12, but the difference lacked clinical significance. This supports oral high-dose therapy as a valid alternative to injections in compliant patients without severe neurological deficits.
Summary: The cornerstone of treatment is parenteral cyanocobalamin or hydroxocobalamin (hydroxocobalamin preferred) for malabsorption-related deficiency, with lifelong monthly maintenance. High-dose oral therapy (1000 mcg/day) is a valid alternative in selected patients. Treat the underlying cause where possible, and never rely on folate alone.
This is a shared conversation. Sign in to Orris to start your own chat.